Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00158158

Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2

Interventions for Tobacco Dependent Adolescents

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Smoking Cessation Tobacco Use Disorder

Interventions Smoking Reduction Usual Care

Updated 6 times since 2017 Last updated: Jan 9, 2017 Started: Sep 30, 2005 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Smoking Cessation and Tobacco Use Disorder, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States